STAR Protocols (Jun 2021)
Modeling human retinoblastoma using embryonic stem cell-derived retinal organoids
Abstract
Summary: Retinoblastoma (Rb) is the most prevalent intraocular malignancy in early childhood. Traditional models are unable to accurately recapitulate the origin and development of human Rb. Here, we present a protocol to establish a novel human Rb organoid (hRBO) model derived from genetically engineered human embryonic stem cells (hESCs). This hRBO model exhibits properties highly consistent with human primary Rb and can be used effectively for dissecting the origination and pathogenesis of Rb as well as for screening of potential therapies.For complete details on the use and execution of this protocol, please refer to Liu et al. (2020).